PCSK9 inhibitors and coronary atherosclerotic plaque modification: a meta-analysis

被引：0
|
作者：
Theofilis, P. [1 ]
Papanikolaou, A. [1 ]
Vlachakis, P. K. [1 ]
Antonopoulos, A. S. [1 ]
Sagris, M. [1 ]
Oikonomou, E. [2 ]
Tsioufis, K. [1 ]
Tousoulis, D. [1 ]
机构：
[1] Hippokrateion Hosp, Athens, Greece
[2] Sotiria Reg Chest Dis Hosp, Athens, Greece
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1402
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
    Zulkapli, Rahayu
    Abd Muid, Suhaila
    Wang, Seok Mui
    Nawawi, Hapizah
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [42] INFLUENCE OF PCSK9 INHIBITION ON BIOMARKERS OF ATHEROSCLEROTIC PLAQUE DESTABILIZATION RELEASE IN PATIENT WITH DYSLIPIDEMIA
    Okopien, B.
    Basiak, M.
    Kosowski, M.
    Hachula, M.
    Szkrobka, W.
    Buldak, L.
    Machnik, G.
    Dziubinska-Basiak, M.
    ATHEROSCLEROSIS, 2023, 379 : S132 - S132
  • [43] THE EFFECT OF PCSK9 INHIBITION ON BIOMARKERS OF ATHEROSCLEROTIC PLAQUE DESTABILIZATION RELEASE IN PATIENT WITH DYSLIPIDEMIA
    Basiak, M.
    Machnik, G.
    Konopka, M.
    Dziubinska-Basiak, M.
    Szkrobka, W.
    Buldak, L.
    Okopien, B.
    ATHEROSCLEROSIS, 2018, 275 : E253 - E254
  • [44] Recent Updates on the Use of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease
    Dave L. Dixon
    Lauren G. Pamulapati
    John D. Bucheit
    Evan M. Sisson
    Shawn R. Smith
    Caroline J. Kim
    George F. Wohlford
    Jonah Pozen
    Current Atherosclerosis Reports, 2019, 21
  • [45] Recent Updates on the Use of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease
    Dixon, Dave L.
    Pamulapati, Lauren G.
    Bucheit, John D.
    Sisson, Evan M.
    Smith, Shawn R.
    Kim, Caroline J.
    Wohlford, George F.
    Pozen, Jonah
    CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (05)
  • [46] PCSK9 Inhibitors Safely and Effectively Lower LDL After Heart Transplantation: A Systematic Review and Meta-Analysis
    Jennings, D. L.
    Sultan, L.
    Mingov, J.
    Choe, J.
    Finnegan, K.
    Latif, F.
    Restaino, S.
    Clerkin, K.
    Yuzefpolskaya, M.
    Sayer, G.
    Uriel, N.
    Baker, W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S408 - S408
  • [47] Nationwide data analysis on adherence to PCSK9 inhibitors
    Stummer, Alissia
    Ristl, Robin
    Kogler, Bernhard
    Muskovich, Melanie
    Kossmeier, Michael
    Stulnig, Thomas M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 261 - 262
  • [48] Analysis of The Use of PCSK9 Inhibitors in Clinical Practice
    Volkova, S. Yu.
    Boyarskaya, L. A.
    Toropygin, P. Yu.
    Morozov, I. A.
    Boyarskaya, E. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (01) : 43 - 49
  • [49] The impact of early in-hospital use of PCSK9 inhibitors on cardiovascular outcomes in acute coronary syndrome patients: A systematic review and meta-analysis
    Deng, Yifan
    Ma, Yue
    Zhang, Yubin
    Gao, Jiapei
    Sun, Xun
    He, Shenghu
    Zhu, Li
    Zhang, Jing
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 399
  • [50] Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta-Analysis of 35 Randomized Controlled Trials
    Karatasakis, Aris
    Danek, Barbara A.
    Karacsonyi, Judit
    Rangan, Bavana V.
    Roesle, Michele K.
    Knickelbine, Thomas
    Miedema, Michael D.
    Khalili, Houman
    Ahmad, Zahid
    Abdullah, Shuaib
    Banerjee, Subhash
    Brilakis, Emmanouil S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12):
12345